Found: 46
Select item for more details and to access through your institution.
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1411, doi. 10.1007/s10637-020-00897-3
- By:
- Publication type:
- Article
Assessing the effects of beta‐blockers on pancreatic cancer risk: A nested case‐control study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 5, p. 599, doi. 10.1002/pds.4993
- By:
- Publication type:
- Article
Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 12, p. 1, doi. 10.1038/s41419-022-05519-9
- By:
- Publication type:
- Article
Combination Treatment of Intratumoral Vidutolimod, Radiosurgery, Nivolumab, and Ipilimumab for Microsatellite Stable Colorectal Carcinoma With Liver Metastases.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 4, p. 442, doi. 10.1016/j.clcc.2023.08.004
- By:
- Publication type:
- Article
Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2345013, doi. 10.1001/jamanetworkopen.2023.45013
- By:
- Publication type:
- Article
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 4, p. 513, doi. 10.1007/s40487-023-00247-2
- By:
- Publication type:
- Article
Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02283-9
- By:
- Publication type:
- Article
The changing face of clinical trials in the personalized medicine and immunooncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2017, v. 36, p. 1, doi. 10.1186/s13046-017-0668-0
- By:
- Publication type:
- Article
SAFETY OUTCOMES OF OLAPARIB AS MAINTENANCE THERAPY FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY FOR PATIENTS WITH BRCA-MUTATED METASTATIC PANCREATIC CANCER: RESULTS FROM THE POLO STUDY.
- Published in:
- Oncology Nursing Forum, 2022, v. 49, n. 2, p. E61, doi. 10.1188/22.ONF.E2
- By:
- Publication type:
- Article
Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231189127
- By:
- Publication type:
- Article
ASO Author Reflections: Pancreatic Cancer Patients with Germline BRCA Mutations Benefit from Early Introduction of Platinum-Based Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 10, p. 3971, doi. 10.1245/s10434-020-08495-6
- By:
- Publication type:
- Article
Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 10, p. 3963, doi. 10.1245/s10434-020-08469-8
- By:
- Publication type:
- Article
Neo-adjuvant doxorubicin and cyclophosphamide followed by paclitaxel in triple-negative breast cancer among BRCA1 mutation carriers and non-carriers.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 1, p. 157, doi. 10.1007/s10549-016-3800-5
- By:
- Publication type:
- Article
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 133, doi. 10.1007/s10549-015-3662-2
- By:
- Publication type:
- Article
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 4, p. 828, doi. 10.1007/s10120-018-00909-5
- By:
- Publication type:
- Article
Harnessing the Perioperative Period to Improve Long-term Cancer Outcomes.
- Published in:
- 2018
- By:
- Publication type:
- editorial
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2018, v. 9, n. 5, p. 871, doi. 10.1002/jcsm.12331
- By:
- Publication type:
- Article
Harnessing synthetic lethality to predict the response to cancer treatment.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04647-1
- By:
- Publication type:
- Article
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.
- Published in:
- Familial Cancer, 2012, v. 11, n. 2, p. 243, doi. 10.1007/s10689-011-9507-1
- By:
- Publication type:
- Article
Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 7, p. 1703, doi. 10.1007/s00432-021-03911-0
- By:
- Publication type:
- Article
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e111, doi. 10.1002/onco.13542
- By:
- Publication type:
- Article
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e671, doi. 10.1634/theoncologist.2018-0333
- By:
- Publication type:
- Article
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.
- Published in:
- Oncologist, 2017, v. 22, n. 7, p. 804, doi. 10.1634/theoncologist.2016-0415
- By:
- Publication type:
- Article
Effect of the botanical compound LCS102 on innate immunity.
- Published in:
- Biomedical Reports, 2020, v. 13, n. 3, p. N.PAG, doi. 10.3892/br.2020.1323
- By:
- Publication type:
- Article
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 10, p. 1472, doi. 10.1002/cam4.491
- By:
- Publication type:
- Article
Diffusion Tensor Magnetic Resonance Imaging of the Pancreas.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0115783
- By:
- Publication type:
- Article
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 256, doi. 10.1002/cncr.35052
- By:
- Publication type:
- Article
Patient‐centered outcomes in the POLO study of active maintenance olaparib for germline BRCA‐mutated metastatic pancreatic cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 9, p. 1411, doi. 10.1002/cncr.34610
- By:
- Publication type:
- Article
Loss of Function RET Gene Variant and Cancer: Co-occurrence or an Association?
- Published in:
- Israel Medical Association Journal, 2023, v. 25, n. 6, p. 445
- By:
- Publication type:
- Article
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 3084, doi. 10.1002/cncr.28143
- By:
- Publication type:
- Article
Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 20, p. 20353, doi. 10.1002/cam4.6621
- By:
- Publication type:
- Article
Chimeric molecule IL-6/soluble IL-6 receptor is a potent mitogen for fetal hepatocytes.
- Published in:
- Journal of Cellular Physiology, 2004, v. 200, n. 2, p. 245, doi. 10.1002/jcp.20019
- By:
- Publication type:
- Article
Targeting DNA Damage Repair Mechanisms in Pancreas Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4259, doi. 10.3390/cancers13174259
- By:
- Publication type:
- Article
The Discussions Continue.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
Targeting the Insulin Growth Factor Pathway in Gastrointestinal Cancers.
- Published in:
- Oncology (08909091), 2011, v. 25, n. 6, p. 518
- By:
- Publication type:
- Article
Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 11637, doi. 10.2147/OTT.S276814
- By:
- Publication type:
- Article
Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?
- Published in:
- Molecular & Clinical Oncology, 2019, v. 10, n. 5, p. 555
- By:
- Publication type:
- Article
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/681653
- By:
- Publication type:
- Article
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical & Translational Gastroenterology, 2022, v. 13, n. 5, p. e00473, doi. 10.14309/ctg.0000000000000473
- By:
- Publication type:
- Article
Recapitulating the clinical scenario of BRCA‐associated pancreatic cancer in pre‐clinical models.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 1, p. 179, doi. 10.1002/ijc.31292
- By:
- Publication type:
- Article
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article